Cargando…
Inhibition of the Exocyst Complex Attenuates the LRRK2 Pathological Effects
Pathological mutations in leucine-rich repeat kinase 2 (LRRK2) gene are the major genetic cause of Parkinson’s disease (PD). Multiple lines of evidence link LRRK2 to the control of vesicle dynamics through phosphorylation of a subset of RAB proteins. However, the molecular mechanisms underlying thes...
Autores principales: | Ciampelli, Cristina, Galleri, Grazia, Puggioni, Silvia, Fais, Milena, Iannotta, Lucia, Galioto, Manuela, Becciu, Marta, Greggio, Elisa, Bernardoni, Roberto, Crosio, Claudia, Iaccarino, Ciro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454163/ https://www.ncbi.nlm.nih.gov/pubmed/37628835 http://dx.doi.org/10.3390/ijms241612656 |
Ejemplares similares
-
Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype
por: Rassu, Mauro, et al.
Publicado: (2019) -
LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8
por: Fais, Milena, et al.
Publicado: (2021) -
Parkinson’s Disease-Related Genes and Lipid Alteration
por: Fais, Milena, et al.
Publicado: (2021) -
Role of LRRK2 in the regulation of dopamine receptor trafficking
por: Rassu, Mauro, et al.
Publicado: (2017) -
Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: Dangerous Liaisons
por: Sini, Paola, et al.
Publicado: (2021)